市場調查報告書
商品編碼
1370418
細胞激素市場:2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測Cytokine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
2022年全球細胞激素市場規模達833億美元。展望未來,IMARC Group預計到2028年市場規模將達到1,305億美元,2023-2028年年複合成長率(CAGR)為7.66%。
細胞激素是指特定細胞釋放的一組蛋白質、勝肽或糖蛋白,用於控制免疫系統和血球的生長和活性。由於其高親和力皮莫耳濃度,它可以調節免疫、發炎和造血功能。它通常被注射到皮下或肌肉或靜脈中,以幫助預防或控制化療副作用並治療癌症。它還透過發送使異常細胞死亡和正常細胞壽命更長的訊號來增強抗癌活性。目前,它在細胞和基因治療、各種細胞類型的擴增和分化、離體培養和其他治療方法中已被廣泛採用。
冠狀病毒病 (COVID-19) 透過飛沫傳播,飛沫可誘導促炎細胞因子過量產生,導致急性呼吸窘迫症候群 (ARDS) 加重和組織損傷。由於組織損傷可能導致多重器官衰竭和死亡,因此對細胞因子來管理患者、提高存活率並降低死亡率的解決方案的需求不斷增加。除此之外,癌症盛行率的不斷上升,加上對微創手術(MIS)的需求不斷增加,微創手術可以減少術後疼痛和併發症,並加快恢復時間,從而促進了市場的成長。此外,由於細胞因子可作為健康和疾病的診斷、預後和治療劑以及生物標記物,因此它們在多種功能中越來越受到關注,包括免疫細胞分化、發炎、血管生成、腫瘤發生、神經生物學和病毒發病機轉。除此之外,異位性皮膚炎(AD) 是一種複發性、慢性、發炎性皮膚病,伴隨嚴重搔癢,其病例不斷增加,正在推動AD 發病機制中對新細胞因子的需求,並開發改進的治療標靶。
The global cytokine market size reached US$ 83.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 130.5 Billion by 2028, exhibiting a growth rate (CAGR) of 7.66% during 2023-2028.
A cytokine refers to a group of proteins, peptides, or glycoproteins released by specific cells to control the growth and activity of the immune system and blood cells. It can regulate immunity, inflammation, and hematopoiesis on account of its high-affinity picomolar concentrations. It is usually injected under the skin or into muscles or veins to help prevent or manage chemotherapy side effects and treat cancer. It also boosts anti-cancer activities by sending signals that make abnormal cells die and normal cells live longer. Presently, it is gaining widespread adoption in cell and gene therapy for the expansion and differentiation of various cell types, ex vivo cultures, and other therapeutic approaches.
The coronavirus disease (COVID-19) is transmitted via droplets that can induce the excessive production of proinflammatory cytokines and lead to acute respiratory distress syndrome (ARDS) aggravation and tissue damage. As tissue damage can result in multi-organ failure and death, there is a rise in the demand for solutions that target cytokines to manage patients, improve survival rates, and reduce mortality. Apart from this, the increasing prevalence of cancer, in confluence with the escalating demand for minimally invasive surgeries (MIS) that provide less post-operative pain and complications and faster recovery time, is contributing to the market growth. Moreover, as cytokines act as diagnostic, prognostic, and therapeutic agents and biomarkers for health and diseases, they are gaining traction in diverse functions, including immune cell differentiation, inflammation, angiogenesis, tumorigenesis, neurobiology, and viral pathogenesis. Besides this, the rising cases of atopic dermatitis (AD), a recurrent, chronic, and inflammatory skin disease that processes with severe itchiness, is driving the demand for new cytokines in the pathogenesis of AD and developing improved therapeutic targets.
IMARC Group provides an analysis of the key trends in each sub-segment of the global cytokine market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on cytokine type, therapeutic application and end user.
Tumor Necrosis Factor-TNF
Interleukins-Il
Interferons-IFN
Epidermal Growth Factor-EGF
Others
Cancer
Asthma and Airway Inflammation
Arthritis
Others
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Academic and Research Institutes
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
How has the global cytokine market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global cytokine market?
What are the key regional markets?
What is the breakup of the market based on the cytokine type?
What is the breakup of the market based on the therapeutic application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global cytokine market and who are the key players?
What is the degree of competition in the industry?